Tratamiento psicofarmacológico de la conducta agresiva en niños y adolescentes disociales

Descargas

Publicado

1998-09-30

Cómo citar

Olza, l., Velilla, M. J., Paumard, C., & ´Bonals, A. (1998). Tratamiento psicofarmacológico de la conducta agresiva en niños y adolescentes disociales. Revista De Psiquiatría Infanto-Juvenil, (3), 194–200. Recuperado a partir de https://aepnya.eu/index.php/revistaaepnya/article/view/457

Número

Núm. 3 (1998): Julio-Septiembre

Sección

Artículo de revisión

Autores/as

  • l. Olza Hospital Clínico Universitario Lozano Blesa
  • M. J. Velilla Hospital Clínico Universitario Lozano Blesa
  • C. Paumard Hospital Clínico Universitario Lozano Blesa
  • A. ´Bonals Hospital Clínico Universitario Lozano Blesa

Palabras clave:

Agresividad, Conducta disocial, Farmacoterapia

Resumen

Hay pocos estudios que investiguen directamente la eficacia de los psicofármacos para tratar la agresividad infantil. A pesar de ello, la polifarmacia es una práctica frecuente en los trastornos de conducta. Existen indicios de que una alteración de la serotonina favorece la conducta agresiva en los niños disociales y en los hiperactivos agresivos. Sin embargo, la eficacia de los inhibidores selectivos de la recaptación de la serotonina para el control de la agresividad en los niños y adolescentes no ha sido probada. El litio sigue siendo el tratamiento mejor estudiado, pero todavía no se han identificado los marcadores de respuesta al mismo. Los antiepilépticos son de elección, siempre que exista una alteración Jel EEG, pero no está claro su eficacia cuando el EEG es normal. El metilfenidato puede ser una opción válida en adolescentes disociales. La hospitalización y el placebo también deberían ser considerados para disminuir la conducta agresiva.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Carrasco Perera JL, Sáiz Ruiz J. Biología de las conductas violentas. En: La violencia y sus víctimas. Mononografías de Psiquiatría 1998 ;X(1) :2-5.

Coccaro EF. Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int Clin Psychopharmacol 1992; 7(1):3-12. https://doi.org/10.1097/00004850-199200710-00001

Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 1997; 154(10):1430-5. https://doi.org/10.1176/ajp.154.10.1430

Cleare AJ, Bond AJ, Does central serotonergic function correlate inversely with aggression? A study using D- fenfluramine in healthy subjects. Psychiatry Res 1997;69(2- 3):89-95. https://doi.org/10.1016/S0165-1781(96)03052-1

New AS, Trestman RL, Mitropoulou V, Benishay DS, Coccaro E, Silverman J, Siever LJ. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res 1997;69(l):17-26. https://doi.org/10.1016/S0165-1781(96)02784-9

American Psychiatric Association. DSM-IV. Editorial Masson; 1995.

Unis AS, Cook EH, Vincent JG, Gjerde DK, Perry BD, et al. Platelet serotonin measures in adolescents with conduct disorder. Biol Psychiatry 1997;42(7):553-9. https://doi.org/10.1016/S0006-3223(96)00465-9

Halperin JM, Newcorn JH, Schwartz ST, Sharma V, Siever LJ, Koda VH, Gabriel S. Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biol Psychiatry 1997;41(6):682-9. https://doi.org/10.1016/S0006-3223(96)00168-0

Connor DF, Steingard RJ. A clinical approach to the pharmacotherapy of aggression in children and adolescents. Ann NY Acad Sci 1996;794:290-307. https://doi.org/10.1111/j.1749-6632.1996.tb32529.x

Connor DF, Ozbayrak KR, Kusiak KA, Caponi AB, Melloni RH Jr. Combined pharmacotherapy in children and adolescents in a residential treatment center. J Am Acad Child Adolesc Psychiatry 1997;36(2) :248-54. https://doi.org/10.1097/00004583-199702000-00016

Kazdin AE. Tratamiento de la conducta antisocial en la infancia y la adolescencia. Barcelona: Editorial Martínez Roca; 1988.

Campbell M, Cueva JE. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II. J Am Acad of Child Adol Psych 1995;34(10): 1262-72. https://doi.org/10.1097/00004583-199510000-00011

Campbell M, Kantafaris V, Cueva JE. An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder. Psychopharmacol Bull 1995;31(1):93- 102.

Campbell M, Adams PB, Small AM, Kantafaris V, Silva RR, Shell J, Perry R, Overall JE. Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo controlled study. J Am Acad Child Adol Psych 1995;34(4):445-53. https://doi.org/10.1097/00004583-199504000-00011

Rifkin A, Karajgi B, Dicker R, Perl E, Boppana V, Hasan N, Pollack S. Lithium treatment of conduct disorders in adolescents. Am J Psychiatry 1997; 154(4):554-5. https://doi.org/10.1176/ajp.154.4.554

Malone RP, Luebbert J, Pena-Ariet M, Biesecker K, Delaney MA. The Overt Aggression Scale in a study of lithium in aggressive conduct disorder. Psychopharmacol Bull 1994; 30(2):215-8.

Barratt ES, Stanford MS, Felthous AR, Kent TA. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychopharmacol 1997;(5) :341-9. https://doi.org/10.1097/00004714-199710000-00002

Donovan SJ, Susser ES, Nunes EV, Stewart JW, Quitkin FM, Klein DF. Divalproex treatment of disruptive adolescents: a report of 10 cases. J Clin Psychiatry 1997;58(1): 12-5. https://doi.org/10.4088/JCP.v58n0102

Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M. Carbamazepine in aggressive children with conduct disorder: a double-bind and placebo controlled study. J Am Acad Child Adol Psych 1996;35(4):480-90. https://doi.org/10.1097/00004583-199604000-00014

Fava M. Psychopharmacological treatment of pathologic aggression. Psychiatric Clin North Am 1997;20(2):427-51. https://doi.org/10.1016/S0193-953X(05)70321-X

Horrigan JP, Barnhill LJ. Risperidone and explosive aggressive autism. J Autism Dev Dis 1997;27(3):313-23. https://doi.org/10.1023/A:1025854532079

Hinshaw SP, Heller T, McHale JP. Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate. J Consult Clin Psychol 1992;60(2):274-81. https://doi.org/10.1037/0022-006X.60.2.274

Klein RG, Abikoff H, Klass E, Gáneles D, Seese LM, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention déficit hyperactivity disorder. Arch Gen Psychiatry 1997;54(12): 1073-80. https://doi.org/10.1001/archpsyc.1997.01830240023003

Malone RP, Luebbert JF, Delaney MA, Biesecker KA, Blaney BL, Rowan AB, Campbell M. Nonpharmacological response in hospitalized children with conduct disorder. J Am Acad Child Adol Psych 1997;36(2):242-7. https://doi.org/10.1097/00004583-199702000-00015

Sánchez LE, Armenteros JL, Small AM, Campbell M, Adams PB. Placebo response in aggressive children with conduct disorder. Psychopharmacol Bull 1994;30(2):209-13.

Dodman NH, Donnelly R, Shuster L, Mertens P, Rand W, Miczek K. Use of fluoxetine to treat dominance aggression in dogs. J Am Vet Med Assoc 1996;209(9): 1585-7.

Fuller RW. The influence of fluoxetine on aggressive behavior. Neuropsychopharmacol 1996;14(2):77-81. https://doi.org/10.1016/0893-133X(95)00110-Y

Coccaro EF, Kavoussi RJ, Hauger RL. Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biol Psychiatry 1997;42(7):546-52. https://doi.org/10.1016/S0006-3223(97)00309-0

Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55(4): 137-41.

Constantino JN, Liberman M, Kincaid M. Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial. J Child Adolesc Psychopharmacol 1997;7(1):31-44. https://doi.org/10.1089/cap.1997.7.31

Finkelstein JW, Susman EJ, Chinchilli VM, Kunselman SJ, D'Arcangelo MR, Schwab J, Demers LM, Liben LS, Lookingbill G, Kulin HE. Estrogen or testosterone increases self-reported aggressive behaviors in hypogonadal adolescents. J Clin Endocrinol Metab 1997;82(8):2433-8. https://doi.org/10.1210/jc.82.8.2433

Schvehla TJ, Mandoki MW, Summer GS. Clonidine therapy for comorbid attention déficit hyperactivity disorder and conduct disorder. Preliminary findings in a children's inpatient unit. Southern Med J 1994; 87(7): 692-5. https://doi.org/10.1097/00007611-199407000-00004